Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-022-01061-4.pdf
Reference212 articles.
1. Abd El-Mageed HR, Abdelrheem DA, Rafi M, Sarker M, Al-Khafaji K, Hossain M, Capasso R, Emran TB (2021) In silico evaluation of different flavonoids from medicinal plants for their potency against SARS-CoV-2. Biologics 1(3):416–434
2. Abdallah HM, El-Halawany AM, Sirwi A, El-Araby AM, Mohamed GA, Ibrahim SRM, Koshak AE, Asfour HZ, Awan ZA, Elfaky MA (2021) Repurposing of some natural product isolates as SARS-COV-2 main protease inhibitors via in vitro cell free and cell-based antiviral assessments and molecular modeling approaches. Pharmaceuticals 14(3):213
3. Ackermann M, Mentzer SJ, Kolb M, Jonigk D (2020a) Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow. Eur Resp J 56(5):2003147
4. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A (2020b) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383(2):120–128
5. Adelodun B, Ajibade FO, Ibrahim RG, Ighalo JO, Bakare HO, Kumar P, Eid EM, Kumar V, Odey G, Choi KS (2022) Insights into hazardous solid waste generation during COVID-19 pandemic and sustainable management approaches for developing countries. J Mater Cycle Waste Manage 23(6):2077–2086
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Etiological and immunopathogenetic aspects of multiorgan failure development in coronavirus disease (COVID-19);Zaporozhye Medical Journal;2024-07-17
2. Lycopene as a Therapeutic Agent against Aflatoxin B1-Related Toxicity: Mechanistic Insights and Future Directions;Antioxidants;2024-04-11
3. Lycopene: Extraction, microencapsulation, and therapeutic properties;Bioresource Technology Reports;2024-02
4. Novel antioxidant protein target therapy to counter the prevalence and severity of SARS-CoV-2;Frontiers in Immunology;2024-01-03
5. CRISPR/Cas: A Genome-Editing Tool for Crops Improvement;Gene Editing in Plants;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3